17378-99-3

Usage

Uses

Used in Fragrance Industry:
2-[2-(2-hydroxyethyl)phenyl]ethanol is used as a fragrance ingredient for its pleasant aroma, enhancing the scent profiles of perfumes and personal care products.
Used in Industrial Applications:
This chemical compound serves as a solvent in various industrial processes, leveraging its ability to dissolve other substances effectively.
Used in Antiseptic and Disinfectant Products:
2-[2-(2-hydroxyethyl)phenyl]ethanol is utilized as an antimicrobial and antibacterial agent in antiseptic solutions and disinfectants, helping to prevent the spread of infections and maintain cleanliness.
Given its low toxicity and general safety when handled properly, 2-[2-(2-hydroxyethyl)phenyl]ethanol is a versatile chemical with applications across different industries.

InChI:InChI=1/C10H14O2/c11-7-5-9-3-1-2-4-10(9)6-8-12/h1-4,11-12H,5-8H2

Upstream product

• 17532-66-0 ethyl 2-[2-(2-ethoxy-2-oxoethyl)phenyl]acetate 
• 7500-53-0 1,2-Phenylenediacetic acid 
• 613-73-0 1,2-phenylenediacetonitrile 
• 19109-69-4 (o-Phenylen)bis(essigsaeure-methylester) 

Downstream Products

• 91-14-5 1,2-divinylbenzene 
• 17379-00-9 1,2-Bis(2-bromoethyl)benzene 
• 121688-11-7 monoacetate of 1,2-benzenediethanol 
• 130800-04-3 1,2-phenylenebis(ethane-2,1-diyl) dimethanesulfonate 
• 121688-10-6 1,2-benzenediethanol monotosylate 
• 145509-75-7 1,2-benzenediethanol ditosylate 
• 128846-13-9 1,2-bis(2-acetylthioethyl)benzene 
• 321906-45-0 1,2-bis-[2-(2-methoxy-ethoxymethoxy)-ethyl]-benzene 
• 497157-41-2 2-{2-[2-(tert-butyldimethylsilanyloxy)-ethyl]-phenyl}-ethanol 
• 149274-10-2 tert-butyldimethyl-[2-(2-vinylphenyl)-ethoxy]-silane 
• 915315-73-0 (E)-1-(4,8-dimethylnona-3,7-dienyl)-2-vinylbenzyl 
• 915315-72-9 (E)-2-[2-(4,8-dimethylnona-3,7-dienyl)-phenyl]-ethanol 
• 915315-69-4 tert-butyldimethyl-(2-{2-[2-(2-nitrophenylselanyl)-ethyl]-phenyl}-ethoxy)-silane 
• 915315-52-5 (E)-tert-butyl-{2-[2-(4,8-dimethylnona-3,7-dienyl)-phenyl]-ethoxy}-dimethylsilane 

Relevant academic research and scientific papers

Compound as potassium channel modulator

The invention relates to a compound as a potassium channel modulator, which is a compound of a formula (I) or a pharmaceutically acceptable salt thereof. The compound or the pharmaceutically acceptable salt thereof is effective for curing and preventing diseases and symptoms influenced by the activity of potassium ion channels.

HETEROCYCLIC COMPOUNDS AS AXL INHIBITORS

Compounds of Formula I and their uses of effective AXL inhibitors and for the treatment of physical condition mediated by AXL.

Synthesis of 3-substituted tetrahydrofuran and 4-substituted tetrahydropyran derivatives by cyclization of dicarboxylic acids with InBr 3/TMDS

An efficient reduction followed by cyclization of diacid compounds with the InBr3/TMDS system is reported. This system allows the formation of five- and six-membered ring ethers substituted in the 3- or 4-position. Copyright

FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS

The present invention provides a compound of formula I or II or a pharmaceutically acceptable salt form thereof, wherein R1, R2, R3, R4, R5, A1, A2, A3, A4, and A5, are as defined herein. The compounds of formula I or II have ALK and/or c-Met inhibitory activity, and may be used to treat proliferative disorders.

Application of the B-alkyl Suzuki-Miyaura cross-coupling reaction to the stereoselective synthesis of analogues of (3S)-oxidosqualene

(Chemical Equation Presented) A general method is described for the direct and stereoselective synthesis of epoxypolyenes via Suzuki-Miyaura cross-coupling reaction of 1-iodoalkenes with B-alkylboron compounds. It allows for the straightforward and conver

Tetrahydrobenzazepines and their use

The invention relates to tetrahydrobenzazepines of the general formula I in which the variables Ar, A, B, Y, R1 and R2 have the meaninigs indicated in claim 1, as well as the N-oxides of these compounds, the physiologically tolerated acid addition salts of these compounds and the physiologically tolerated acid addition salts of the N-oxides. The invention also relates to a pharmaceutical compositon that comprises at least one tetrahydrobenzazepine compound of the formula I, the physically tolerated acid addition salt of I, the N-oxide of compound of the formula I and/or the physically tolerated acid addition salts of the N-oxides of I, and further to the use of a compound according to the present invention for treating disorders that respond benefically to dopamine D3 receptor antagonists or dopamine D3 agonists. The compounds according to the invention are preferably useful for the treatment of disorders of the central nervous system such as schizophrenia and depression and for the treatment of renal function disorders.

Synthesis of diastereomerically enriched cyclic homoallylic alcohols using molybdenum π-allyl complexes

Condensation of CpMo(NO)(π-allyl)I complexes bearing a tethered aldehyde gave cyclic homoallylic alcohols with a varying degree of diastereoselectivity. Cyclohexyl and tetrahydronaphthyl derivatives were prepared in moderate to good yields. The diastereos

A New General Synthesis of Polycyclic Aromatic Compounds Based on Enamine Chemistry

Alkylation of enamines and enamine salts by benzylic and (β-haloethyl)aryl halides, respectively, followed by acidic cyclodehydration and dehydrogenation provides an efficient synthetic approach to a wide range of polycyclic aromatic compounds of diverse structural types.Specific polycyclic hydrocarbons synthesized by this route include benzo- and benzofluorene, 7H-dibenzo-, 13H-dibenzo-, and 13H-dibenzofluorene, 15H-tribenzofluorene, dibenzochrysene, benzopentaphene, indenofluorene, fluorenofluorene, octahydrodibenzanthracene, dibenzanthracene, octahydrodibenzanthracene, dibenzanthracene, picene, benzopicene, 1H-benzaceanthrylene, and 4H-cyclopentachrysene.This method with appropriate modifications appears to be potentially broader in scope than established traditional methods of polycyclic hydrocarbon synthesis.

Predicting the stability of cyclic disulfides by molecular modeling: "Effective concentrations" in thiol-disulfide interchange and the design of strongly reducing dithiols

We have tested molecular mechanics calculations at the level of MM2(85) for their capacity to rationalize relationships between structure and equilibrium constants for thiol-disulfide interchange reactions. With 20 α,ω-dithiols taken from the literature, equilibrium constants for thiol-disulfide interchange with 1,2-dithiane were calculated: HSRSH + S(CH2)4S → SRS + HS(CH2)4SH. The relation between experimental values of ΔG and calculated differences in strain energy was ΔG = 0.41ΔSE + 0.5 kJ/mol with a correlation coefficient of 0.93 (excluding one anomalous point). Results from molecular mechanics correlate well with experimental results, but they cannot give absolute values of energies. Results of molecular mechanics calculations are used to discuss the physical interpretation of the concept of "effective concentration" as it is used for the thiol-disulfide interchange reaction.